droxidopa
- Product NDC
- 70436-141
- 11-digit product format
- 704360141
- Labeler code
- 70436
- Product ID
- 70436-141_1af8aeac-14cf-4330-bf4e-3e50348268c1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- droxidopa
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Slate Run Pharmaceuticals, LLC
- Application
- ANDA215265
- Marketing category
- ANDA
- Marketing start
- 2021-11-10
- Substance
- DROXIDOPA
- Active strength
- 200 mg/1
- Pharmacologic classes
- Catecholamines [CS], Increased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- droxidopa
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DROXIDOPA | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J7A92W69L7 |
| Rxcui | 1490026, 1490034, 1490038 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70436-141-06 | droxidopa | 90 in 1 BOTTLE | CAPSULE | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70436-141 | DROXIDOPA CAPSULE [SLATE RUN PHARMACEUTICALS, LLC] | 2 | Current NDC, Legacy NDC, 1 package rows | 20230330_049f997b-1649-467e-bbb9-bdb991b0bc6e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70436-141-06 | 70436014106 | 90 CAPSULE in 1 BOTTLE (70436-141-06) | 90 capsule | 2021-11-10 | 0000-00-00 | No | No | Current |